Quick Dispatch:
Your glp 1 als Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases in: Journal of Endocrinology Volume 221 Issue 1 (2014) orders ship within 1-2 business days.
Delivery Options:
Order Tracking:
You'll receive a tracking link by email once your glp 1 als Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases in: Journal of Endocrinology Volume 221 Issue 1 (2014) ships.
Need Help?
Questions about glp 1 als Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases in: Journal of Endocrinology Volume 221 Issue 1 (2014), sizing, or delivery? We're just an email away.
Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for glp 1 als Central effects of GLP-1: new opportunities for treatments of neurodegenerative diseases in: Journal of Endocrinology Volume 221 Issue 1 (2014) in your area.
The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS
27.95
Anti-Inflammatory Effects of GLP-1 Receptor Activation in the Brain in Neurodegenerative Diseases
26.19
Glucagon-like peptide-1 (GLP-1) receptor agonists and neuroinflammation: Implications for neurodegenerative disease treatment
28.26
Full article: Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists
24.89
The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1G93A and TDP-43Q331K transgenic mouse models of ALS
29.54
Full article: Targeting metabolic dysfunction in amyotrophic lateral sclerosis: therapeutic potential of GLP-1 receptor agonists
25.99
Protective role of IGF-1 and GLP-1 signaling activation in neurological dysfunctions
23.34
